BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

22980

544135

MUKKA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MUKKA PROTEINS LIMITED performance

Today’s low

Today’s high

₹ 31.80 ₹ 32.44
₹ 31.92

52 week low

52 week high

₹ 28.71 ₹ 56.56
₹ 31.92

Open Price

₹ 32.39

Prev. Close

₹ 32.31

Volume (Shares)

267513.00

Total traded value

₹ 85.39

Upper Circuit

₹ 38.77

Lower Circuit

₹ 25.84

info

MUKKA PROTEINS LIMITED Share Price Update

As of the latest trading session, MUKKA PROTEINS LIMITED share price is currently at ₹ 31.92, which is down by ₹ -0.39 from its previous closing. Today, the stock has fluctuated between ₹ 31.80 and ₹ 32.44. Over the past year, MUKKA PROTEINS LIMITED has achieved a return of -12.78 %. In the last month alone, the return has been -3.36 %. Read More...

MUKKA PROTEINS LIMITED fundamentals


  • Market cap (Cr)

    957.60

  • P/E Ratio (TTM)

    18.79

  • Beta

    0.96

  • Book Value / share

    12.20

  • Return on equity

    25.78%

  • EPS (TTM)

    1.70

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    25.10

info icon alternate text
  • Market cap (Cr)

    958.20

  • P/E Ratio (TTM)

    18.79

  • Beta

    0.84

  • Book Value / share

    12.20

  • Return on equity

    25.78%

  • EPS (TTM)

    1.70

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    25.10

info icon alternate text

MUKKA PROTEINS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 279.99
Operating Expense 261.78
Net Profit 25.10
Net Profit Margin (%) 8.96
Earnings Per Share (EPS) 0.84
EBITDA 43.19
Effective Tax Rate (%) 20.79
Particulars SEP 2024 (Values in Cr)
Revenue 121.74
Operating Expense 127.30
Net Profit 2.17
Net Profit Margin (%) 1.78
Earnings Per Share (EPS) 0.07
EBITDA 11.16
Effective Tax Rate (%) -27.48
Particulars JUN 2024 (Values in Cr)
Revenue 142.63
Operating Expense 149.36
Net Profit 1.32
Net Profit Margin (%) 0.92
Earnings Per Share (EPS) 0.04
EBITDA 11.08
Effective Tax Rate (%) 38.20
Particulars MAR 2024 (Values in Cr)
Revenue 223.92
Operating Expense 217.46
Net Profit 22.32
Net Profit Margin (%) 9.96
Earnings Per Share (EPS) 0.99
EBITDA 26.79
Effective Tax Rate (%) -24.97
Particulars DEC 2023 (Values in Cr)
Revenue 468.31
Operating Expense 478.85
Net Profit 9.05
Net Profit Margin (%) 1.93
Earnings Per Share (EPS) 0.41
EBITDA 20.00
Effective Tax Rate (%) 31.43
Particulars MAR 2024 (Values in Cr)
Revenue 1230.82
Operating Expense 1213.77
Net Profit 62.76
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 2.78
EBITDA 101.46
Effective Tax Rate (%) 12.40
Particulars MAR 2023 (Values in Cr)
Revenue 1045.64
Operating Expense 1020.17
Net Profit 39.42
Net Profit Margin (%) 3.76
Earnings Per Share (EPS) 1.79
EBITDA 74.55
Effective Tax Rate (%) 28.43
Particulars MAR 2022 (Values in Cr)
Revenue 692.89
Operating Expense 672.43
Net Profit 19.82
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 0.90
EBITDA 31.91
Effective Tax Rate (%) 29.71
Particulars MAR 2021 (Values in Cr)
Revenue 536.25
Operating Expense 539.34
Net Profit 4.61
Net Profit Margin (%) 0.85
Earnings Per Share (EPS) 0.21
EBITDA 9.05
Effective Tax Rate (%) 23.92
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.20
ROE % 27.33
ROCE % 19.15
Total Debt to Total Equity 1.15
EBITDA Margin 9.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.72
ROE % 38.62
ROCE % 24.01
Total Debt to Total Equity 1.77
EBITDA Margin 8.01
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.47
ROE % 31.32
ROCE % 18.20
Total Debt to Total Equity 2.03
EBITDA Margin 7.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1209.53
ROE % 12.53
ROCE % 9.06
Total Debt to Total Equity 2.44
EBITDA Margin 4.58
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1028.18
ROE % 23.25
ROCE % 14.96
Total Debt to Total Equity 2.23
EBITDA Margin 5.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 12.17
ROE % 25.78
ROCE % 18.08
Total Debt to Total Equity 1.17
EBITDA Margin 8.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.53
ROE % 38.66
ROCE % 23.13
Total Debt to Total Equity 1.96
EBITDA Margin 6.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.74
ROE % 27.31
ROCE % 16.76
Total Debt to Total Equity 1.99
EBITDA Margin 5.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1142.93
ROE % 4.29
ROCE % 5.81
Total Debt to Total Equity 1.98
EBITDA Margin 2.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1046.08
ROE % 20.71
ROCE % 14.99
Total Debt to Total Equity 1.87
EBITDA Margin 4.65
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 126.80
Total Assets 940.79
Total Liabilities 940.79
Total Equity 408.30
Share Outstanding 300000000
Price to Book Ratio 3.00
Return on Assets (%) 7.44
Return on Capital (%) 9.09
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 29.01
Total Assets 575.16
Total Liabilities 575.16
Total Equity 155.84
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 7.66
Return on Capital (%) 10.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.89
Total Assets 392.29
Total Liabilities 392.29
Total Equity 103.07
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 6.17
Return on Capital (%) 8.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.18
Total Assets 354.79
Total Liabilities 354.79
Total Equity 69.92
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 2.52
Return on Capital (%) 3.92
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.65
Total Assets 293.11
Total Liabilities 293.11
Total Equity 57.75
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 4.49
Return on Capital (%) 6.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 123.50
Total Assets 851.13
Total Liabilities 851.13
Total Equity 365.17
Share Outstanding 300000000
Price to Book Ratio 3.00
Return on Assets (%) 7.37
Return on Capital (%) 9.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 23.03
Total Assets 500.03
Total Liabilities 500.03
Total Equity 121.63
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 7.88
Return on Capital (%) 11.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.10
Total Assets 329.07
Total Liabilities 329.07
Total Equity 82.28
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 6.02
Return on Capital (%) 8.16
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 288.38
Total Liabilities 288.38
Total Equity 62.86
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 1.59
Return on Capital (%) 2.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.89
Total Assets 257.37
Total Liabilities 257.37
Total Equity 57.53
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 4.98
Return on Capital (%) 7.73
Particulars MAR 2024 (Values in Cr)
Net Income 87.45
Cash from Operations -124.38
Cash from Investing -47.59
Cash from Financing 265.89
Net change in Cash 67.89
Free Cash Flow -108.76
Particulars MAR 2023 (Values in Cr)
Net Income 65.94
Cash from Operations -45.19
Cash from Investing -3.32
Cash from Financing 74.66
Net change in Cash 15.01
Free Cash Flow -36.98
Particulars MAR 2022 (Values in Cr)
Net Income 35.98
Cash from Operations 10.55
Cash from Investing -11.47
Cash from Financing 14.99
Net change in Cash 8.38
Free Cash Flow 17.06
Particulars MAR 2021 (Values in Cr)
Net Income 15.45
Cash from Operations 6.37
Cash from Investing -13.61
Cash from Financing 13.48
Net change in Cash 1.66
Free Cash Flow 17.05
Particulars MAR 2020 (Values in Cr)
Net Income 19.73
Cash from Operations -19.17
Cash from Investing -27.97
Cash from Financing 53.78
Net change in Cash 0.74
Free Cash Flow 17.22
Particulars MAR 2024 (Values in Cr)
Net Income 71.64
Cash from Operations -121.86
Cash from Investing -43.04
Cash from Financing 258.05
Net change in Cash 70.56
Free Cash Flow -108.97
Particulars MAR 2023 (Values in Cr)
Net Income 55.09
Cash from Operations -38.27
Cash from Investing 0.71
Cash from Financing 61.11
Net change in Cash 14.87
Free Cash Flow -34.95
Particulars MAR 2022 (Values in Cr)
Net Income 28.19
Cash from Operations -12.96
Cash from Investing -7.24
Cash from Financing 27.25
Net change in Cash 4.70
Free Cash Flow -10.60
Particulars MAR 2021 (Values in Cr)
Net Income 6.05
Cash from Operations 1.95
Cash from Investing -5.41
Cash from Financing 8.05
Net change in Cash 0.30
Free Cash Flow 7.36
Particulars MAR 2020 (Values in Cr)
Net Income 18.81
Cash from Operations -18.30
Cash from Investing 1.81
Cash from Financing 22.63
Net change in Cash 0.38
Free Cash Flow -12.59
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5446.05 60.30 40.86 131178.08 4506.50 / 6473.10
NESTLE INDIA LIMITED 2385.45 74.90 57.35 229994.87 2115.00 / 2777.00
FOODS & INNS LIMITED 87.89 26.63 1.25 645.24 75.20 / 164.85
HINDUSTAN UNILEVER LTD. 2341.25 52.78 11.13 550098.05 2136.00 / 3034.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5446.05 61.82 47.29 131178.08 4506.50 / 6473.10
COLGATE PALMOLIVE LTD. 2583.10 48.07 42.50 70256.61 2324.00 / 3893.00
NESTLE INDIA LIMITED 2385.45 74.24 55.86 229994.87 2115.00 / 2777.00
FOODS & INNS LIMITED 87.89 25.62 1.25 645.24 75.20 / 164.85

MUKKA PROTEINS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
31.92 -1.20 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 32.50
  • 26 Days 33.00
  • 10 Days 32.70
  • 50 Days 33.80
  • 12 Days 32.80
  • 100 Days 35.50
  • 20 Days 32.90
  • 200 Days 37.20
32.47 PIVOT

First Support

32.09

First Resistance

32.70

Second Support

31.86

Second Resistance

33.08

Third Support

31.48

Third Resistance

33.31

RSI

41.53

ADX

28.08

MACD

-0.29

Williams % R

-82.30

Commodity Channel Index (CCI)

-89.80

Date

2025-04-30

Week

260162.00

Same Day

149052.00

Month

293607.00

1 Year

0.96

3 Year

1.00

Over 1 Month

-3.36%

down

Over 1 Year

-12.78%

down

Over 3 Months

-12.18%

down

Over 3 Years

0.00%

down

Over 6 Months

-25.92%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MUKKA PROTEINS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
22.05%
Promoter Holdings
73.33%
FII
2.62%
DII
1.98%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Mohammed Haris K 9.06868E7 (30.23%) Shareholding of Promoter and Promoter Group
K Mohammad Arif 4.84004E7 (16.13%) Shareholding of Promoter and Promoter Group
K Mohammed Althaf 4.84004E7 (16.13%) Shareholding of Promoter and Promoter Group
Kalandan Abdul Razak 2.2E7 (7.33%) Shareholding of Promoter and Promoter Group
Umaiyya Banu 1.05112E7 (3.5%) Shareholding of Promoter and Promoter Group
Neomile Growth Fund - Series I 5952956.0 (1.98%) Public Shareholding
Craft Emerging Market Fund Pcc- Elite Capital Fund 3571660.0 (1.19%) Public Shareholding
Multitude Growth Funds Limited 3354475.0 (1.12%) Public Shareholding
Aisha Shabnam 400.0 (0.0%) Shareholding of Promoter and Promoter Group
Razeena Khatheeja 400.0 (0.0%) Shareholding of Promoter and Promoter Group
Zareena Banu 400.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

MUKKA PROTEINS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

MUKKA PROTEINS LIMITED Share Price

Mukka Proteins Limited was originally incorporated as 'Mukka Sea Food Industries', a Partnership firm in Karnataka on March 13, 2003. Subsequently, the Partnership Firm was thereafter converted to Private Company as 'Mukka Sea Food Industries Private Limited' on November 04, 2010. The Company subsequently got converted into Public Limited Company dated December 02, 2019 in the name of 'Mukka Sea Food Industries Limited' and the name of the Company changed to 'Mukka Proteins Limited' vide a fresh certificate of incorporation issued by ROC-Bangalore, dated August 06, 2021.

The Company manufacture fish meal, fish oil and fish soluble paste, an essential ingredient in the manufacturing of aqua feed (for
fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds its application in pharmaceutical products (additionally, the EPA-DHA extraction is used as an ingredient in nutraceuticals), soap manufacturing, leather tanneries & paint industries.

Led by the Founder Promoter, Mr. Kalandan Mohammed Haris, Mukka Group is one of the pioneers in the Fishmeal Industry having set up one of India's first steam sterilised fishmeal plants. They produce Steam Dried Fish Meal, Fish Oil and Fish Soluble Paste from their modern and fully mechanized plant situated in Karnataka and Gujarat, which is geared up to deliver Fish Meal, Fish Oil and Fish Soluble Paste to every corner of the globe. Recently, the Company diversified products by developing alternative proteins such as Black Soldier Fly (BSF) Insect Meal and Insect Oil in the animal food industry.

The Company business is extended to manufacture of High-Quality Fish Meal and Omega-3 Fish Oil which is used as a raw material in aquafeed, poultry feed, pet feed, animal feed, EPA-DHA extraction (use in nutraceuticals - nutrients plus pharmaceuticals), soap manufacture, leather tanneries & Paint industries across globally.

In 2014, the Company commenced International operations in the Middle East.

In 2018, it set up a Manufacturing Facility in Gujarat.

The Company has raised money from public through IPO aggregating upto Rs 224 Crore by issuing 8,00,00,000 Equity Shares through Fresh Issue in March, 2024.

Parent organization Indian Private
NSE symbol MUKKA
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Mukka Proteins Ltd?

Answer Field

The share price of Mukka Proteins Ltd for NSE is ₹ 31.92 and for BSE is ₹ 31.94.

What is the Market Cap of Mukka Proteins Ltd?

Answer Field

The market cap of Mukka Proteins Ltd for NSE is ₹ 9,57.60 Cr. and for BSE is ₹ 9,58.20 Cr. as of now.

What is the 52 Week High and Low of Mukka Proteins Ltd?

Answer Field

The 52 Week High and Low of Mukka Proteins Ltd for NSE is ₹ 56.56 and ₹ 28.71 and for BSE is ₹ 56.52 and ₹ 28.50.

How to Buy Mukka Proteins Ltd share?

Answer Field

You can trade in Mukka Proteins Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mukka Proteins Ltd?

Answer Field

The 1 year returns on the stock has been -12.78%.

What is the Current Share Price of Mukka Proteins Ltd?

Answer Field

Mukka Proteins Ltd share price is for NSE ₹ 31.92 & for BSE ₹ 31.94 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Mukka Proteins Ltd Share?

Answer Field

The market cap of Mukka Proteins Ltd for NSE ₹ 9,57.60 & for BSE ₹ 9,58.20 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Mukka Proteins Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Mukka Proteins Ltd share is 18.79.

What is the PB ratio of Mukka Proteins Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Mukka Proteins Ltd share is 12.20.

How to Buy Mukka Proteins Ltd Share?

Answer Field

You can trade in Mukka Proteins Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mukka Proteins Ltd Share on Bajaj Broking App?

Answer Field

To buy Mukka Proteins Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mukka Proteins Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|